Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 11Terminated 5Recruiting 5Active not recruiting 3Withdrawn 2Enrolling by invitation 1

Sponsor Class

OTHER 10INDUSTRY 5NIH 2NETWORK 2

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Thoracic 2Breast 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Pneumonia 1Lung Diseases, Interstitial 1Leukemia, B-Cell 1

Interventions

pembrolizumab 183Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 53fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 39Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Observation × Clear all
NCT06192004 2026-05-04

LOOP

AstraZeneca

Terminated
83 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

NCT05592483 2024-11-07

DB RESPOND

AstraZeneca

Terminated
78 enrolled
Breast

Breast Neoplasms

NCT06126003 2024-08-02

Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

BioCorteX Inc

Terminated
2 enrolled
Breast

Breast Neoplasms

NCT05032352 2022-11-14

PADMA

Insight Molecular Diagnostics

Terminated
55 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01039376 2019-07-30

PROLONG

Novartis

Phase 3 Terminated
480 enrolled 30 charts
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡